학술논문
Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trial
Document Type
Article
Author
Source
In: The Lancet Oncology . (The Lancet Oncology, April 2023, 24(4):347-359)
Subject
Language
English
ISSN
14745488
14702045
14702045